StockData
Alterity Therapeutics Ltd logo

Alterity Therapeutics Ltd (ATHE) stock

ATHENasdaqPharmaceutical PreparationsFiscal year ends June 30Also trades as PRNAF
Financials through fiscal 2026, year ended Jun 30, 2026Last filing: 20-F on Aug 28, 2026Score 5/30
$1.86−0.09 (-4.85%)

Close on Nov 17, 2026Market cap $33.80MP/E –Yield –

Alterity Therapeutics cash

Cash and short-term investments held at the end of each period.

Alterity Therapeutics's cash was A$37.32M at Jun 30, 2026. For fiscal 2026 it was A$37.32M, up 12.5% from the year before. Over ten years it grew 2.7% a year on average. The highest annual figure on record is A$37.32M in fiscal 2026.

Annual cash

PeriodPeriod endValueChange
FY2026Jun 30, 2026A$37.32M+12.5%
FY2025Jun 30, 2025A$33.16M+162.4%
FY2024Jun 30, 2024A$12.64M-19.9%
FY2023Jun 30, 2023A$15.77M-54.7%
FY2022Jun 30, 2022A$34.81M+23.8%
FY2021Jun 30, 2021A$28.12M+205.7%
FY2020Jun 30, 2020A$9.20M-36.1%
FY2019Jun 30, 2019A$14.40M-5.5%
FY2018Jun 30, 2018A$15.24M-30.4%
FY2017Jun 30, 2017A$21.88M-23.5%
FY2016Jun 30, 2016A$28.59M-18.1%
FY2015Jun 30, 2015A$34.91M–

Quarterly cash

Change is against the same quarter a year earlier.

Periods
PeriodPeriod endValueChange
Q4 FY2026CQ2 2026Jun 30, 2026A$37.32M+7.2%
Q4 FY2025CQ2 2025Jun 30, 2025A$33.16M-10.4%
Q4 FY2024CQ2 2024Jun 30, 2024A$12.64M-55.0%
Q4 FY2023CQ2 2023Jun 30, 2023A$15.77M-55.0%
Q4 FY2022CQ2 2022Jun 30, 2022A$34.81M+278.5%
Q2 FY2022CQ4 2021Dec 31, 2021A$37.00M+203.8%
Q4 FY2021CQ2 2021Jun 30, 2021A$28.12M+95.2%
Q2 FY2021CQ4 2020Dec 31, 2020A$35.04M+130.0%
Q4 FY2020CQ2 2020Jun 30, 2020A$9.20M-58.0%
Q2 FY2020CQ4 2019Dec 31, 2019A$12.18M-57.4%
Q4 FY2019CQ2 2019Jun 30, 2019A$14.40M-58.8%
Q4 FY2018CQ2 2018Jun 30, 2018A$15.24M–
Q4 FY2017CQ2 2017Jun 30, 2017A$21.88M–
Q4 FY2016CQ2 2016Jun 30, 2016A$28.59M–
Q4 FY2015CQ2 2015Jun 30, 2015A$34.91M–

More Alterity Therapeutics figures

See a number that looks wrong?